De Novo device
IDx-DR
Idx, LLC · Diabetic Retinopathy Detection Device (PIB, Class II) · First FDA decision Apr 11, 2018, newest Apr 11, 2018DiabetesMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "IDx-DR"
MAUDE reports
0
Brand "IDx-DR", since 2015
PubMed studies
39
Mentioning "IDx-DR"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- IDx-DRNew device typeBreakthroughDe Novo
DEN180001 · Decided Apr 11, 2018 · 89 days after receipt
Device type: Diabetic Retinopathy Detection Device (PIB) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "IDx-DR", any status and sponsor, newest update first.
Digital Diagnostics, Inc.Not on our public-company list
NCT02963441 · 900 participants · Start Jan 2017 · Primary completion Nov 2017
Device: LumineticsCore (formerly IDX-DR) · For: Diabetic Retinopathy
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "IDx-DR", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PIB
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "IDx-DR"[tiab]. The summary above synthesizes these.
- IDx-DR for Diabetic Retinopathy Screening.
Savoy M · Am Fam Physician · 2020
- The application of artificial intelligence in diabetic retinopathy: progress and prospects.
Xu X, Zhang M, Huang S, et al. · Front Cell Dev Biol · 2024Review
- Diagnostic Accuracy of Automated Diabetic Retinopathy Image Assessment Softwares: IDx-DR and Medios Artificial Intelligence.
Grzybowski A, Rao DP, Brona P, et al. · Ophthalmic Res · 2023
- Variability of Grading DR Screening Images among Non-Trained Retina Specialists.
Grzybowski A, Brona P, Krzywicki T, et al. · J Clin Med · 2022
- Diagnostic Accuracy of IDX-DR for Detecting Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
Khan Z, Gaidhane AM, Singh M, et al. · Am J Ophthalmol · 2025Systematic Review, Meta-Analysis
- Application of Artificial Intelligence in Ophthalmology: An Updated Comprehensive Review.
Hashemian H, Peto T, Ambrósio R, et al. · J Ophthalmic Vis Res · 2024Review
- Evaluation of IDx-DR software for diabetic retinopathy screening in outpatient clinics: Efficacy, safety, and feasibility in a real-world setting.
Huber SL, Parzer V, Ludvik B, et al. · J Diabetes Complications · 2025
- AI-Human Hybrid Workflow Enhances Teleophthalmology for the Detection of Diabetic Retinopathy.
Dow ER, Khan NC, Chen KM, et al. · Ophthalmol Sci · 2023
- Autonomous artificial intelligence versus teleophthalmology for diabetic retinopathy.
Musetti D, Cutolo CA, Bonetto M, et al. · Eur J Ophthalmol · 2025Comparative Study
- Prospective validation of deep-learning algorithms for diabetic retinopathy screening: A systematic review and meta-analysis.
Wang TW, Luo WT, Tu YK, et al. · Surv Ophthalmol · 2026Systematic Review, Meta-Analysis
- Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System.
van der Heijden AA, Abramoff MD, Verbraak F, et al. · Acta Ophthalmol · 2018Validation Study
- Artificial intelligence in diabetic retinopathy: A natural step to the future.
Padhy SK, Takkar B, Chawla R, et al. · Indian J Ophthalmol · 2019Review
Other devices of this type
Also filed under product code PIB.
- Aeye-DsAeye Health, Inc. · 510(k) 2024
- iPredict-DRiHealthscreen, Inc. · 510(k) 2026
- EyeArt v2.2.0Eyenuk, Inc. · 510(k) 2023
- IDx-DR v2.3Digital Diagnostics, Inc. · 510(k) 2022
- IDx-DRDigital Diagnostics, Inc. · 510(k) 2021
- EyeArtEyenuk, Inc. · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.